Bristol-Myers Squibb to Present at Bank of America Merrill Lynch 2015 Health Care Conference
The Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015, in Las Vegas. Doug Manion, ...
The Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015, in Las Vegas. Doug Manion, ...
Canada-based Valeant Pharmaceuticals International has completed the acquisition of US-based Salix Pharmaceuticals for around $11bn. Under the deal, Valeant ...
US-based Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement with Japanese firm Mitsubishi Tanabe Pharma to develop ...
Novartis has received approval from the US Food and Drug Administration (FDA) for its Jadenu (deferasirox) tablets to treat patients ...
BioCryst Pharmaceuticals has received a $35m contract to continue developing BCX4430, a drug that has shown early signs of fighting ...
US-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a ...
Cipher Pharmaceuticals Inc., a rapidly growing specialty pharmaceutical dermatology company, has licensed the Canadian distribution rights to CF101, a novel ...
Although essential marine omega-3 fatty acids and vitamin D have been shown to improve cognitive function and behavior in the ...
University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells. This ...
Salix Pharamaceuticals and Indian pharmaceutical company Lupin announced Friday that they have entered into a distribution agreement that grants Lupin ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
